Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | CNR2 | P34972 | 1/20 | 0.47 |
| ▸ | CRHR1 | P34998 | 2/20 | 0.47 |
| ▸ | NOS1 | P29475 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.43 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.43 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | JAK2 | O60674 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11292840 | 0.91 | MAPT (0.50) | MAPTTSHRNOS1SMN1; SMN2AOC3 | |
| SCHEMBL8059710 | 0.80 | NOS1 (0.42) | MAPTTSHRNOS1SMN1; SMN2AOC3 | |
| SCHEMBL14869399 | 0.80 | SMN1; SMN2 (0.58) | MAPTTSHRSMN1; SMN2AOC3RAB9A | |
| SCHEMBL2339204 | 0.78 | MAPT (0.60) | MAPTTSHRSMN1; SMN2 | |
| SCHEMBL12609970 | 0.77 | TSHR (0.64) | MAPTTSHRCNR2CRHR1SMN1; SMN2 | |
| SCHEMBL2726098 | 0.77 | SMN1; SMN2 (0.48) | MAPTTSHRCNR2CRHR1SMN1; SMN2 | |
| SCHEMBL7754258 | 0.76 | NPSR1 (0.57) | SMN1; SMN2 | |
| SCHEMBL2338559 | 0.74 | MAPT (0.66) | MAPTTSHRSMN1; SMN2RAB9A | |
| SCHEMBL10807532 | 0.73 | TSHR (0.75) | MAPTTSHRCNR2CYP2C19NPC1 | |
| SCHEMBL179996 | 0.72 | TSHR (1.00) | MAPTTSHRCNR2PDE4DCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10640475-B2 | Compositions and methods to produce alkoxylated triazine-arlhydroxy-aldehyde condensates | HEXION INC. (US) | 2020-05-05 | — | — | US | disclosed |
| US-10604614-B2 | Compositions and methods to produce alkoxylated triazine-arylhydroxy-aldehyde condensates | HEXION INC. (US) | 2020-03-31 | — | — | US | disclosed |
| US-20190092736-A1 | NOVEL COMPOSITIONS AND METHODS TO PRODUCE ALKOXYLATED TRIAZINE-ARLHYDROXY-ALDEHYDE CONDENSATES | JPMORGAN CHASE BANK, N.A. | 2019-03-28 | — | — | US | disclosed |
| US-20190092894-A1 | NOVEL COMPOSITIONS AND METHODS TO PRODUCE ALKOXYLATED TRIAZINE-ARYLHYDROXY-ALDEHYDE CONDENSATES | JPMORGAN CHASE BANK, N.A. | 2019-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10640475-B2 | Compositions and methods to produce alkoxylated triazine-arlhydroxy-aldehyde condensates | ALKBH3, AHR, AKR7A2 | MAPT 2972/4885TSHR 3675/4885CNR2 1093/4885 |
| US-20190092736-A1 | NOVEL COMPOSITIONS AND METHODS TO PRODUCE ALKOXYLATED TRIAZINE-ARLHYDROXY-ALDEHYDE CONDENSATES | ALKBH3, ALKBH5, ALKBH2 | MAPT 3262/4885TSHR 3812/4885CNR2 952/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.